Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C > T and EX6 del) in the PARK2 gene

Ana Marote, Yuriy Pomeshchik, Stefano Goldwurm, Anna Collin, Nuno J. Lamas, Luísa Pinto, António J. Salgado, Laurent Roybon

Research output: Contribution to journalArticlepeer-review

3 Citations (SciVal)

Abstract

Mutations in the PARK2 gene, which encodes PARKIN, are the most frequent cause of autosomal recessive Parkinson's disease (PD). We report the generation of an induced pluripotent stem cell (iPSC) line from a 78-year-old patient carrying a compound heterozygous mutation (c.823C > T and EX6del) in the PARK2 gene. Skin fibroblasts were reprogrammed using the non-integrating Sendai virus technology to deliver OCT3/4, SOX2, c-MYC and KLF4 factors. The generated cell line CSC-44 exhibits expression of common pluripotency markers, in vitro differentiation into the three germ layers and normal karyotype. This iPSC line can be used to explore the association between PARK2 mutations and PD.

Original languageEnglish
Pages (from-to)90-94
Number of pages5
JournalStem Cell Research
Volume27
DOIs
Publication statusPublished - 2018 Mar 1

Subject classification (UKÄ)

  • Medical Genetics
  • Neurosciences

Fingerprint

Dive into the research topics of 'Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C > T and EX6 del) in the PARK2 gene'. Together they form a unique fingerprint.

Cite this